Jon Sewell, special projects manager (Aseptic Filling Program Lead), Origin, looks at the rise of cleanrooms-on-demand in the pharma manufacturing sector, the challenges it helps to overcome and whether this could become the future blueprint.
Key insights:
- The new AAS service-centred model is filtering into the pharma industry, manufacturers are able to control value creation, avoid backlogs with CDMOs and remain agile.
- For both biotech start-ups through to big pharma, COD can help to eliminate capital expenditure, enhance IP protection, provide greater control and increase speed to clinic or market.
- Cleanroom operators are expected to offer more flexible services through modular configurations to meet the ever-changing needs of customers and respond to the ‘unpredictabilities’ of project execution.
Sterile manufacturing is a highly complex and stringent area of production and requires expert skill sets, high capital expenditure and technologies.